WYY NYSE Services-Computer Integrated Systems Design Financials FY2016βFY2025
Widepoint Corp had $151M of revenue in fiscal 2025, up 5.6% on the year before. Over five years, revenue changed +48.8% a year on average.
Last close Β· Oct 23, 2026
$6.81
4.9%Hi! I read Widepoint Corpβs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+5.6%
Yes. Sales grew 5.6% last year.
Does it make a profit?
β1.8%
No. It lost money last year.
Does profit turn into cash?
3.6%
Partly. 3.6% of sales ends up as free cash.
How healthy are the accounts?
3 / 8
Weak. It passes 3 of 8 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA Β· Widepoint Corp had $151M of revenue in fiscal 2025, up 5.6% on the year before. Over five years, revenue changed +48.8% a year on average. Its operating margin was β1.8%, down 0.5Β pts: of every 100 in sales, about β2 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Widepoint Corp lost $2.8M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was $5.5M in fiscal 2025, 3.6% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· In the last 12 months, insiders bought $0.0M and sold $7.3M of shares on the open market.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
2 insiders
Sold, 12 months
$7.3M
5 insiders
Of sales under plans
8%
$0.6M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 9, 2026 | Todd DzyakCOO | Sold | 5,000 | $12.75 | $0.1M | Form 4 |
| Jul 6, 2026 | John J FitzgeraldDirector | Sold | 15,000 | $15.63 | $0.2M | Form 4 |
| Jun 29, 2026 | Robert J GeorgeChief Financial Officer | Sold | 16,882 | $16.16 | $0.3M | Form 4 |
| Jun 26, 2026 | Ian SparlingCEO, Soft-Ex | Sold | 155,449 | $16.67 | $2.6M | Form 4 |
| Jun 26, 2026 | Jason HollowayEVP and Chief Sales and Market | Sold | 181,740 | $17.25 | $3.1M | Form 4 |
| Jun 26, 2026 | Robert J GeorgeChief Financial Officer | Sold | 15,863 | $18.17 | $0.3M | Form 4 |
| Jun 25, 2026 | Todd DzyakCOO | Sold plan | 10,000 | $24.00 | $0.2M | Form 4 |
| Jun 24, 2026 | Todd DzyakCOO | Sold plan | 10,000 | $17.50 | $0.2M | Form 4 |
| Jun 23, 2026 | Todd DzyakCOO | Sold plan | 10,000 | $15.00 | $0.2M | Form 4 |
| May 29, 2026 | Robert J GeorgeChief Financial Officer | Sold | 10,000 | $10.59 | $0.1M | Form 4 |
| Jan 2, 2026 | Jin KangCEO, Director | Bought | 1,000 | $5.61 | $0.0M | Form 4 |
| Jan 2, 2026 | Philip N GarfinkleDirector | Bought | 1,000 | $5.35 | $0.0M | Form 4 |
| Dec 29, 2025 | Jin KangCEO, Director | Bought | 1,000 | $5.55 | $0.0M | Form 4 |
| Dec 26, 2025 | Philip N GarfinkleDirector | Bought | 1,500 | $5.58 | $0.0M | Form 4 |
Can it carry its debts, and how well does it use its money?
Cash, debt and the ratios that show how comfortably Widepoint Corp can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $6.5M | $7.5M | $6.9M | $6.8M | $9.8M |
| Interest coverage | 2.2x | β75.6x | β15.5x | β7.7x | β13.8x |
| Current ratio | 1.3x | 1.1x | 1.0x | 1.0x | 1.0x |
| Quick ratio | 1.3x | 1.1x | 1.0x | 1.0x | 1.0x |
| Total assets | $75.5M | $49.0M | $51.3M | $71.6M | $79.8M |
| Total liabilities | $33.8M | $31.3M | $36.6M | $58.0M | $68.3M |
| Shareholders' equity | $41.7M | $17.8M | $14.7M | $13.6M | $11.5M |
| Net debt (β = net cash) | β | β | β | β | β |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Widepoint Corp passes 3 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 9 | 4 / 9 | 5 / 8 | 5 / 8 | 3 / 8 | 4 / 8 | 4 / 8 | 4 / 8 | 3 / 8 |
| Accruals ratio | β14.5% | β1.2% | 1.5% | β10.1% | 4.8% | 1.8% | β47.6% | β9.3% | β5.9% | β11.2% |
| Altman Z'' | β2.86 | β3.76 | β3.25 | β2.29 | β0.17 | β0.60 | β7.38 | β5.42 | β3.76 | β3.62 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $78.4M | $75.9M | $83.7M | $102M | $20.7M | $87.3M | $94.1M | $106M | $143M | $151M |
| Gross profit | $14.0M | $13.7M | $15.3M | $17.4M | $20.5M | $16.4M | $14.6M | $15.6M | $19.0M | $21.0M |
| Research and development | $0.7M | $0.2M | $0.0M | β | β | β | β | β | β | β |
| Operating income | β$4.2M | β$3.5M | β$0.2M | $0.9M | $3.2M | $0.6M | β$19.6M | β$3.7M | β$1.9M | β$2.8M |
| Interest expense | $0.1M | $0.1M | $0.1M | $0.3M | $0.3M | $0.3M | $0.3M | $0.2M | $0.2M | $0.2M |
| Pretax income | β$4.2M | β$3.5M | β$0.3M | $0.6M | β$7.4M | $0.6M | β | β$3.9M | β$1.9M | β$2.7M |
| Income tax | β$0.1M | $0.0M | $1.2M | $0.4M | β$2.9M | $0.6M | $5.1M | $0.1M | β$0.0M | $0.1M |
| Net income | β$4.1M | β$3.5M | β$1.5M | $0.2M | $10.3M | $0.3M | β$23.6M | β$4.0M | β$1.9M | β$2.8M |
| Diluted EPS | β$0.05 | β$0.04 | β$0.02 | $0.03 | $1.20 | $0.04 | β$2.70 | β$0.46 | β$0.21 | β$0.28 |
| Diluted shares | 0.08B | 0.08B | 0.08B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $2.7M | β$3.0M | β$2.1M | $5.9M | $6.4M | β$1.2M | $6.1M | $0.6M | $1.7M | $5.7M |
| Capital expenditure | $0.3M | $0.7M | $0.3M | $0.4M | $0.3M | $0.3M | $0.2M | $0.2M | $0.1M | $0.2M |
| Free cash flow | $2.4M | β$3.7M | β$2.4M | $5.5M | $6.1M | β$1.5M | $5.8M | $0.4M | $1.6M | $5.5M |
| Depreciation and amortization | $0.4M | $0.3M | $0.4M | $1.0M | $1.1M | $1.0M | $1.1M | $0.4M | $0.4M | $0.7M |
| Stock-based compensation | $0.3M | $0.4M | $0.7M | $0.7M | $0.8M | $0.9M | $0.5M | $1.0M | $1.2M | $0.8M |
| Share buybacks | β | β | β | β | β | $8.0M | $0.8M | $0.0M | β | β |
| Dividends and buybacks | β | β | β | β | β | $8.0M | $0.8M | $0.0M | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $9.1M | $5.3M | $2.4M | $6.9M | $16.0M | $6.5M | $7.5M | $6.9M | $6.8M | $9.8M |
| Total debt | $0.5M | $0.3M | $0.5M | β | β | β | β | β | β | β |
| Finance lease liabilities | β | β | β | $0.1M | $0.0M | β | β | β | β | β |
| Current assets | $22.9M | $22.3M | $24.2M | $36.5M | $67.5M | $33.1M | $28.0M | $32.8M | $55.3M | $66.2M |
| Current liabilities | $18.0M | $19.7M | $20.5M | $31.5M | $54.4M | $26.0M | $26.1M | $31.5M | $52.9M | $63.9M |
| Inventory | $0.1M | $0.2M | $0.2M | $0.2M | $1.0M | $0.6M | $0.2M | $0.4M | $0.3M | $0.7M |
| Property and equipment, net | $0.7M | $1.3M | $1.0M | $0.7M | $0.6M | $0.8M | $1.0M | $0.8M | $0.5M | $0.5M |
| Goodwill | $18.6M | $18.6M | $18.6M | $18.6M | $18.6M | $22.1M | $5.8M | $5.8M | $5.8M | $5.8M |
| Intangible assets | $4.3M | $3.7M | $3.1M | $2.5M | $2.2M | $6.2M | $7.4M | $7.3M | $5.1M | $3.4M |
| Total assets | $47.2M | $45.9M | $47.1M | $64.3M | $101M | $75.5M | $49.0M | $51.3M | $71.6M | $79.8M |
| Total liabilities | $18.9M | $20.7M | $22.6M | $39.4M | $60.8M | $33.8M | $31.3M | $36.6M | $58.0M | $68.3M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $28.3M | $25.2M | $24.4M | $24.9M | $40.6M | $41.7M | $17.8M | $14.7M | $13.6M | $11.5M |
| Margins | ||||||||||
| Gross margin | 17.9% | 18.0% | 18.2% | 17.1% | 99.1% | 18.7% | 15.5% | 14.8% | 13.3% | 14.0% |
| Operating margin | β5.3% | β4.6% | β0.2% | 0.9% | 15.6% | 0.7% | β20.9% | β3.5% | β1.3% | β1.8% |
| EBITDA margin | β4.9% | β4.1% | 0.3% | 1.8% | 20.9% | 1.9% | β19.7% | β3.1% | β1.1% | β1.4% |
| Net margin | β5.3% | β4.7% | β1.7% | 0.2% | 50.0% | 0.4% | β25.1% | β3.8% | β1.4% | β1.8% |
| FCF margin | 3.1% | β4.9% | β2.9% | 5.4% | 29.7% | β1.7% | 6.2% | 0.4% | 1.1% | 3.6% |
| Returns | ||||||||||
| Return on capital | β16.7% | β13.5% | β0.7% | β | β | β | β | β | β | β |
| Return on capital employed | β14.3% | β13.2% | β0.7% | 2.7% | 6.9% | 1.2% | β85.9% | β18.7% | β10.1% | β17.5% |
| Return on equity | β14.6% | β13.2% | β5.9% | 0.9% | 31.5% | 0.8% | β79.4% | β25.0% | β13.7% | β21.9% |
| Return on assets | β8.8% | β7.6% | β3.1% | 0.4% | 12.5% | 0.4% | β37.9% | β8.1% | β3.1% | β3.6% |
| Return on tangible equity | β76.2% | β118.5% | β52.8% | 5.8% | 52.1% | 2.6% | β519.3% | β264.6% | β71.5% | β116.2% |
| Growth | ||||||||||
| Revenue growth | β | β3.2% | 10.3% | 21.6% | β79.7% | 322.9% | 7.7% | 12.7% | 34.5% | 5.6% |
| Net income growth | β | β | β | β | 4,462.0% | β96.7% | β7,014.5% | β | β | β |
| EPS growth | β | β | β | β | 3,900.0% | β96.7% | β6,850.0% | β | β | β |
| FCF growth | β | β251.3% | β | β | 11.8% | β124.2% | β | β92.8% | 275.0% | 249.7% |
| Share count change | β | 0.3% | 0.4% | β89.9% | 2.4% | 6.5% | β4.7% | 1.1% | 5.5% | 3.8% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β8.6x | β | β | β | β | β | β | β |
| Debt / equity | 0.0x | 0.0x | 0.0x | β | β | β | β | β | β | β |
| Interest coverage | β57.7x | β66.3x | β2.4x | 2.9x | 10.6x | 2.2x | β75.6x | β15.5x | β7.7x | β13.8x |
| Current ratio | 1.3x | 1.1x | 1.2x | 1.2x | 1.2x | 1.3x | 1.1x | 1.0x | 1.0x | 1.0x |
| Quick ratio | 1.3x | 1.1x | 1.2x | 1.2x | 1.2x | 1.3x | 1.1x | 1.0x | 1.0x | 1.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.4% | 0.9% | 0.3% | 0.4% | 1.2% | 0.3% | 0.3% | 0.2% | 0.1% | 0.2% |
| Stock comp / revenue | 0.4% | 0.5% | 0.8% | 0.7% | 3.9% | 1.0% | 0.6% | 0.9% | 0.8% | 0.5% |
| Payouts / FCF | β | β | β | β | β | β | 14.1% | 0.0% | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 4.0 | 5.0 | 5.0 | 3.0 | 4.0 | 4.0 | 4.0 | 3.0 |
| Altman Z'' | β2.9 | β3.8 | β3.3 | β2.3 | β0.2 | β0.6 | β7.4 | β5.4 | β3.8 | β3.6 |
| Accruals ratio | β14.5% | β1.2% | 1.5% | β10.1% | 4.8% | 1.8% | β47.6% | β9.3% | β5.9% | β11.2% |
Source: SEC EDGAR XBRL filings (CIK 0001034760). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
